Inhibitors of the p130Cas-Crk/CrkL axis, once developed, would enable researchers to tease out the tumor cell migration and invasion that require both p130Cas and Crk/CrkL from the tumor cell migration and invasion that depend on either p130Cas or Crk/CrkL. Here, CRKL is linked to neoplasm.